NYSE:HIMS - Hims & Hers Health Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.00
  • Forecasted Upside: 74.42 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$8.60
▲ +0.11 (1.30%)

This chart shows the closing price for HIMS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hims & Hers Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HIMS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HIMS

Analyst Price Target is $15.00
▲ +74.42% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is $15.00, with a high forecast of $20.00 and a low forecast of $12.00. The average price target represents a 74.42% upside from the last price of $8.60.

This chart shows the closing price for HIMS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 polled investment analysts is to hold stock in Hims & Hers Health. This rating has held steady since March 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/6/2021Bank of AmericaInitiated CoverageNeutral$12.00Low
5/26/2021Credit Suisse GroupUpgradeNeutral ➝ OutperformHigh
5/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$16.00Low
5/19/2021CitigroupBoost Price TargetBuy$16.00 ➝ $20.00High
4/21/2021Truist FinancialInitiated CoverageHoldMedium
4/21/2021Truist SecuritiesInitiated CoverageHold$12.00High
4/21/2021TruistInitiated CoverageHold$12.00High
3/19/2021Piper SandlerLower Price TargetNeutral$20.00 ➝ $18.00High
3/9/2021Credit Suisse GroupInitiated CoverageNeutral$16.00Low
3/2/2021CitigroupUpgradeNeutral ➝ Buy$23.00Medium
2/17/2021CitigroupInitiated CoverageNeutral$23.00Low
2/12/2021Piper SandlerInitiated CoverageNeutral$20.00Low
2/8/2021Tigress FinancialInitiated CoverageBuyLow
(Data available from 7/25/2016 forward)
Hims & Hers Health logo
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Read More

Today's Range

Now: $8.60
Low: $8.19
High: $8.87

50 Day Range

MA: $11.41
Low: $8.49
High: $15.35

52 Week Range

Now: $8.60
Low: $7.96
High: $25.40

Volume

2,059,093 shs

Average Volume

1,686,418 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Hims & Hers Health?

The following Wall Street research analysts have issued stock ratings on Hims & Hers Health in the last year: Bank of America Co., Citigroup Inc., Credit Suisse Group AG, Piper Sandler, Tigress Financial, Truist, Truist Financial Co., Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for HIMS.

What is the current price target for Hims & Hers Health?

6 Wall Street analysts have set twelve-month price targets for Hims & Hers Health in the last year. Their average twelve-month price target is $15.00, suggesting a possible upside of 74.4%. Citigroup Inc. has the highest price target set, predicting HIMS will reach $20.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $12.00 for Hims & Hers Health in the next year.
View the latest price targets for HIMS.

What is the current consensus analyst rating for Hims & Hers Health?

Hims & Hers Health currently has 5 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HIMS, but not buy more shares or sell existing shares.
View the latest ratings for HIMS.

What other companies compete with Hims & Hers Health?

Other companies that are similar to Hims & Hers Health include 1Life Healthcare, Cano Health, LifeMD, Skylight Health Group, Concord Medical Services and WellQuest Medical & Wellness.

How do I contact Hims & Hers Health's investor relations team?

Hims & Hers Health's physical mailing address is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. The company's listed phone number is 800-368-0038 and its investor relations email address is [email protected] The official website for Hims & Hers Health is www.forhims.com.